Benjamin Edwards Inc
BEAM icon

Benjamin Edwards Inc’s Beam Therapeutics BEAM Stock Holding History

Benjamin Edwards Inc’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Sell
31,009
-643
-2% -$19.4K 0.01% 779
2026
Q1 		$754K Sell
31,652
-4,150
-12% -$115K 0.01% 852
2025
Q4 		$992K Buy
35,802
+3,074
+9% +$78.4K 0.01% 717
2025
Q3 		$794K Buy
32,728
+1,072
+3% +$21.3K 0.01% 773
2025
Q2 		$538K Buy
31,656
+5,342
+20% +$93K 0.01% 830
2025
Q1 		$514K Buy
26,314
+1,956
+8% +$51.2K 0.01% 769
2024
Q4 		$604K Buy
24,358
+8,043
+49% +$205K 0.01% 769
2024
Q3 		$400K Buy
16,315
+16,168
+10,999% +$418K 0.01% 873
2024
Q2 		$3K Sell
147
-91
-38% -$2.23K ﹤0.01% 655
2024
Q1 		$8K Buy
238
+7
+3% +$218 ﹤0.01% 649
2023
Q4 		$6K Buy
231
+14
+6% +$348 ﹤0.01% 600
2023
Q3 		$5K Buy
217
+56
+35% +$1.5K ﹤0.01% 598
2023
Q2 		$5K Buy
161
+106
+193% +$3.44K ﹤0.01% 606
2023
Q1 		$2K Buy
55
+36
+189% +$1.42K ﹤0.01% 658
2022
Q4 		$1K Buy
+19
New +$851 ﹤0.01% 698

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Benjamin Edwards Inc's BEAM Position: Q2 2026 in Review

Benjamin Edwards Inc reduced its Beam Therapeutics (BEAM) stake by 2% in Q2 2026, selling an estimated $19.4K and leaving 31,009 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #779.

Benjamin Edwards Inc first reported a position in BEAM in Q4 2022 and has held it in 15 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Benjamin Edwards Inc held 31,009 shares of Beam Therapeutics worth $1.06M as of Q2 2026.
  • Benjamin Edwards Inc sold 643 Beam Therapeutics shares in Q2 2026, an estimated $19.4K.
  • Beam Therapeutics made up 0.01% of Benjamin Edwards Inc's portfolio in Q2 2026, its #779 holding.
  • Benjamin Edwards Inc first reported a position in Beam Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.